Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Invasive Adenocarcinoma of the Breast
Interventions: PROCEDURE: Cryoablation|BIOLOGICAL: Ipilimumab
Sponsor: Memorial Sloan Kettering Cancer Center